相关实验视频
Updated: Jul 25, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
POCT错误可能导致错误的结果.
1Clinical Laboratory Department, Hospital Universitario La Paz, Madrid, Spain.
Advances in laboratory medicine
|June 26, 2023
概括
血液样本中的血液溶解可能会在临床检测期间导致不准确的值,导致误诊. 在临床检测计划中,适当的质量控制对于确保可靠的结果和患者安全至关重要.
科学领域:
- 临床化学 临床化学
- 临床诊断 临床诊断 临床诊断 临床诊断
- 实验室医学 实验室医学
背景情况:
- 护理点检测 (POCT) 为关键决策提供快速结果,但样品质量至关重要.
- 血液气体分析仪在紧急情况下被广泛使用,通常用于全血样本.
- 血液样本中常见的问题是血液溶解,它可以显著影响测试结果.
研究的目的:
- 审查POCT中由于血液溶解导致度错误升高的原因.
- 突出血液溶解诱导的伪高血症的诊断和临床影响.
- 强调实验室主导的POCT程序在错误预防中的作用.
主要方法:
- 文献综述侧重于POCT中的血解和测量.
- 分析血溶如何影响血液气体分析仪的参数.
- 讨论诊断陷和临床后果.
主要成果:
- 血液溶解是伪高血症 (假高) 或伪正常血症 (假正常) 的常见原因.
- 这些变化可能导致错误的诊断和不适当的患者管理.
- POCT 设备通常无法检测样品血液溶解,视觉检测通常不可靠.
结论:
- 准确的POCT结果取决于样本的完整性,特别是血液溶解的缺乏.
- 临床实验室必须实施强大的POCT程序,以减轻与血液溶解有关的错误.
- 有效的质量管理对于安全可靠的临床检测至关重要.
相关概念视频
Errors occurring during blood pressure monitoring
781
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
781
Antihypertensive Drugs: Potassium-Sparing Diuretics
654
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
654
Diagnosing Acidosis and Alkalosis
273
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
273
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
Accuracy and Errors in Hypothesis Testing
229
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
229
Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217

